Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-12-025725)

Filing Details

Accession Number:: 0001104659-12-025725
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-04-16 19:00:59
Reporting Period:: 2012-04-13

Filing Date:: 2012-04-16
Accepted Time:: 2012-04-16 18:00:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1213037	Trovagene Inc.	TROV	Biological Products, (No Disgnostic Substances) (2836)	043721895

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1253803	Gabriel Cerrone	C/O Synergy Pharmaceuticals, Inc. 420 Lexington Avenue, Suite 1609 New York NY 10170		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-04-13	200,000	$0.50	3,940,356	No	4	P	Indirect	By Panetta Partners Ltd.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Panetta Partners Ltd.

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants	Acquisiton	2012-04-13	200,000	$0.00	200,000	$0.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,184,498	2012-04-13	2018-12-31	No	4	P	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	37,500	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Warrants	$0.50	2011-01-06	2018-12-31	37,500	37,500	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2018-12-31	37,500	37,500	Direct

Footnotes

Mr. Cerrone is the sole managing partner of Panetta Partners, Ltd. and in such capacity exercises voting and dispositive control over securities owned by Panetta despite him having only a small pecuniary interest in such securities.